Caissa Capital Management ltd. 4
4 · Avalo Therapeutics, Inc. · Filed May 24, 2023
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-05-24$2.96/sh+5,519$16,348→ 1,382,700 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-05-24$3.01/sh+3,481$10,468→ 1,377,181 total(indirect: See Footnote (1))
Holdings
- 182,300
Common Stock
Footnotes (4)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.0 to $3.01, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.92 to $3.03, inclusive.
- [F4]These shares are directly owned by Mr. Golestaneh in his personal capacity.